Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2000
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375843A1 Compositions and methods for inhibiting cell death
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2373336A1 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000CA2373277A1 Immunity generation
12/14/2000CA2345030A1 Composition and method for the treatment of endotoxic shock and inflammatory and autoimmune diseases in mammals
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058689A1 Alpha-ketoamide inhibitors of 20s proteasome
12/13/2000EP1058560A1 Topical ophthalmic preparations containing immunosuppressive agents
12/13/2000EP1058558A1 Live recombined vaccines injected with adjuvant
12/13/2000EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12
12/13/2000EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276833A Vaccine
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276379A Polypeptide-thyrocalcitonin 11 and polynucleotide for coding same
12/13/2000CN1276235A Chinese-medicinal band for therapy
12/13/2000CN1276234A Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059325C Health-care beer
12/12/2000US6160175 Naphthyl acetamides as sPLA2 inhibitors
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160012 Leukotriene B4 derivatives, in particular oximo-LTB4 - antagonists
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159937 Immunomodulators
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159478 Genetic engineering
12/12/2000US6159472 Intradermal Avian immunization with inactivated vaccines
12/12/2000US6159471 Room temperature storable immunoglobulin preparation for intravenous injection
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000CA2063417C Antiviral composition
12/12/2000CA2023560C 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073460A2 Modified cytokine for its stabilisation
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073439A1 Pollinosis-associated gene 465
12/07/2000WO2000073438A1 Tumor-associated antigen (c42)
12/07/2000WO2000073415A2 A method for the transfer of antigens to dendritic cells
12/07/2000WO2000073349A1 Dr4 antibodies and uses thereof
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073306A1 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072879A1 TREATING ALLERGIC DISEASES WITH IMMUNOTHERAPY AND IgE ANTAGONISTS
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072868A2 Peptides for therapeutic use
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072698A1 Process and product for enhancing immune response in companion animal using a combination of antioxidants
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000WO2000038708A9 Treatment and prevention of immune rejection reactions
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2376133A1 Tumor-associated antigen (c42)
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375349A1 A method for the transfer of antigens to dendritic cells
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 1172